Q3 2025 Aurora Spine Corp Earnings Call Transcript
Key Points
- Aurora Spine Corp (ASAPF) reported October as its best month on record by revenue, indicating strong sales momentum.
- The company successfully launched two new products, Hydra A.R.O. and DEXA-L, which are expected to be key growth drivers.
- Aurora Spine Corp (ASAPF) has expanded its internal sales force and distribution partners, enhancing its market reach.
- The SiLO platform continues to be a major revenue contributor, with over $2 million in sales for the third quarter.
- The company is transitioning to more proprietary products, which is expected to improve gross margins and profitability.
- Total revenues for the third quarter of 2025 decreased by 7.1% compared to the same quarter a year ago.
- The company experienced a decline in lumbar sales due to the transition from a third-party lumbar screw to its own product.
- Operating expenses remain high, although they have decreased slightly from the previous quarter.
- Aurora Spine Corp (ASAPF) reported a net loss of $842,000 for the third quarter of 2025, compared to a net income in the same quarter last year.
- The company lost a significant customer due to the transition away from a third-party product, impacting sales negatively.
Good day and welcome to the Aurora Spine third quarter financial year 2025 results conference call. (Operator Instructions)
Please note that this event is being recorded. I would now like to turn the conference over to Adam Lowensteiner, Vice President of Lytham Partners. Please go ahead.
Thank you, [Chloe]. Welcome everyone, and thank you for joining us today to conduct an update with investors and review the financial results for Aurora Spine for the third quarter fiscal year 2025 that ended September 30, 2025. With us on the call representing the company today are Trent Northcutt, President and CEO of Aurora Spine; Matt Goldstone, Chief Commercial Officer; and Chad Clouse, Chief Financial Officer.
Before we begin, I would like to remind everyone that statements made during the course of this call may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Act of 1934. These statements reflect current
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
